25 November 2021
\n \n \n \nOxford researchers involved nearly 4,000 children across the UK in three specially developed science lessons to educate pupils about brain development during early childhood. The SEEN (Secondary Education around Early Neurodevelopment) project was commissioned and funded by KindredSquared and is part of a wider drive to increase public understanding of how early experiences can shape the adults we become.
\n \n\n \n \n16 November 2021
\n \n \n \nFour researchers in the Department of Psychiatry are in the Highly Cited Researcher 2021 list.
\n \n\n \n \n4 November 2021
\n \n \n \nNew research conducted by the Neuroscience, Ethics and Society group and NeurOX Young People\u2019s Advisory Group in the Department of Psychiatry at the University of Oxford, and the NSPCC, has looked at how Childline\u2019s message boards help support young people.
\n \n\n \n \n2 November 2021
\n \n \n \nThis year's annual meeting focused again on research related to the impact of the COVID-19 pandemic on suicide and self-harm. There was another session on online safety in the context of suicidal behaviour and the Online Safety Bill. Organised by the Centre for Suicide Research, University of Oxford, these virtual workshops for both senior and early career researchers from the UK and Ireland provide an important opportunity to share knowledge and discuss the latest research. This year there were also contributions from Australia and Denmark.
\n \n\n \n \n1 November 2021
\n \n \n \nThe recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.
\n \n\n \n \n21 October 2021
\n \n \n \nA new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.
\n \n\n \n \n11 October 2021
\n \n \n \nDr Angharad de Cates and Dr Liliana Capit\u00e3o were just two of the department's researchers presenting and publishing new research at the European College of Neuropsychopharmacology (ECNP) Conference 2021, in Lisbon.
\n \n\n \n \n8 October 2021
\n \n \n \nIn a new policy briefing, a team of researchers at King\u2019s College London and Oxford University highlight the multiple effects that the COVID-19 pandemic has had on children and young people in the UK through their education and daily life, including challenges around social isolation, academic pressures, adjusting to online learning and coping with reopening of schools.
\n \n\n \n \n5 October 2021
\n \n \n \nProfessor John Geddes, WA Handley-elect Chair of Psychiatry, is one of the thirty-three University of Oxford researchers, which have been named Turing Fellows for the 2021/22 academic year.
\n \n\n \n \n30 September 2021
\n \n \n \nNew research shows that even a very simple intervention, administered by non-specialists with just 15 hours of training, can effectively treat depression during COVID-19.
\n \n\n \n \n29 September 2021
\n \n \n \nA new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.
\n \n\n \n \n28 September 2021
\n \n \n \n\n \n \n28 September 2021
\n \n \n \nThe OxWell School Survey 2021 highlights that younger children and adolescents are the least willing to have the COVID-19 vaccination. These young people come from the most socioeconomically deprived backgrounds, feel less belonging to their school community and think they have probably had COVID-19 already.
\n \n\n \n \n14 September 2021
\n \n \n \nThe International Public Policy Observatory's (IPPO) Rapid Evidence Review has now been released. Co-authored by Professor Cathy Creswell, the Review was commissioned by the UK Department for Education following a recommendation from the Scientific Advisory Group for Emergencies (SAGE).
\n \n\n \n \n2 September 2021
\n \n \n \nThis new study using Canadian and Swiss data showed that the risk calculator used to predict the likelihood of developing a major mood disorder was correct approximately 70% of the time. The study results suggest this may be a useful clinical tool in routine practice for improved individualised risk estimation of bipolar spectrum disorders among the adolescent offspring of a parent with a bipolar disorder.
\n \n\n \n \n3 August 2021
\n \n \n \nNew research found that secondary school students with access to on-site school provision were more likely to report symptoms of depression and anxiety, as well as perceiving their mental wellbeing to have deteriorated during the first national lockdown, compared to students receiving remote school provision. Importantly, the poorer mental health for the group accessing school was explained by their different backgrounds and certain risk factors, such as past mental health needs and upcoming examinations.
\n \n\n \n \n3 August 2021
\n \n \n \nUsing the electronic health records of over 5 million people aged under 30, researchers in the Oxford University Department of Psychiatry found that eating disorders were diagnosed significantly more commonly in 2020 than in previous years, with the rate increasing steadily throughout the year.
\n \n\n \n \n2 August 2021
\n \n \n \nThe athletes competing in the Olympics mount a tremendous responsibility on their shoulders. Representing the pinnacle of human performance, Olympians are not merely idolized for their athletic abilities, but also often praised for their moral character, sportsmanship, and/or mental resilience.
\n \n\n \n \n19 July 2021
\n \n \n \nNew research shows that by lessening the severity and impact of persecutory symptoms of psychosis, it may be possible to reduce the likelihood of someone with psychosis having thoughts of suicide or harming themselves.
\n \n\n \n \n9 July 2021
\n \n \n \nFeeling Safe is a new treatment programme for persecutory delusions, which promises a step change in the treatment of severe mental health problems.
\n \n\n \n \n